Oman: Guidance concerning administrative tax disputes and VAT zero-rating for medicines
Oman: Guidance concerning VAT zero-rating for medicines
The Ministry of Justice and Legal Affairs issued guidance (decisions), one concerning the operating procedures of the Tax Grievance Committee and the other concerning the zero-rating of value added tax (VAT) for certain medicines and medical devices.
- Decision Number 57/2021 addresses the processes of the Tax Grievance Committee (the entity that is responsible for adjudicating income tax, VAT, and excise tax-related “grievances” which is the second stage of tax disputes following objections). The rules require certain information be supplied in disputes (for instance, that three copies of administrative appeals be filed in Arabic and within 45 days of the date of the notification).
- Decision Number 59/2021 provides for the VAT zero-rating of supply of medicines, herbal medicines, biological products, health products, food for medical use, and medical devices. The effective date of this guidance is 16 April 2021.
Read an April 2021 report prepared by the KPMG member firm in Oman
© 2022 KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organization please visit https://home.kpmg/governance.
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.